IMCR Company Profile and Key Details

Q: Who are the executives of IMCR?

Mr. Sébastien DesprezVice President of Communications & Corporation AffairsClayton RobertsonHead of Investor RelationsMs. Lily HepworthGen. Counsel & Company Sec.Dr. David Berman M.D., Ph.D.Head of R&DMs. Amy Judge-PreinChief Compliance OfficerDr. Bahija Jallal Ph.D.Chief Executive Officer & DirectorMs. Tina St. LegerChief HR Officer & DirectorMs. Annelise Vuidepot Ph.D.Chief Technology Officer and Head of Pipeline & Platform ResearchMs. Debra NielsenChief of StaffMr. Brian R. Di Donato M.B.A.Chief Financial Officer & Head of Strategy

NASDAQ : IMCR

Immunocore

$30.92

-0.58-1.84%

At Close 4:00 PM

41.37

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Immunocore Holdings plc (IMCR) stock declined over -1.84%, trading at $30.92 on NASDAQ, down from the previous close of $31.50. The stock opened at $31.41, fluctuating between $30.60 and $31.94 in the recent session.

Stock Snapshot

31.5

Prev. Close

1.56B

Market Cap

30.6

Day Low

-53.31

P/E Ratio

-0.58

EPS (TTM)

Cash Flow per Share

31.41

Open

50.47M

Number of Shares

31.94

Day High

97.67%

Free Float in %

0.01

Book Value

1.1M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 05, 2026	31.41	31.94	30.60	30.92	1.14M
Feb 04, 2026	32.19	32.95	31.34	31.50	366.59K
Feb 03, 2026	33.12	33.49	31.41	32.07	382.88K
Feb 02, 2026	32.49	33.26	32.26	33.04	241.67K
Jan 30, 2026	32.42	33.26	31.68	32.55	757.5K
Jan 29, 2026	33.07	33.39	32.33	33.00	426.48K
Jan 28, 2026	35.11	35.20	32.59	33.13	825.95K
Jan 27, 2026	35.12	35.89	34.73	35.05	619.37K
Jan 26, 2026	35.02	35.79	34.34	35.06	377.47K
Jan 23, 2026	34.93	35.55	34.54	35.11	630.43K
Jan 22, 2026	35.51	35.95	34.70	35.03	642.43K
Jan 21, 2026	33.25	35.57	33.18	35.29	1.04M
Jan 20, 2026	33.00	34.01	33.00	33.33	393.88K
Jan 16, 2026	32.50	33.92	32.50	33.35	582.18K
Jan 15, 2026	33.14	33.51	32.00	32.75	536.45K
Jan 14, 2026	32.50	34.71	32.21	33.13	477.34K
Jan 13, 2026	32.50	32.93	31.77	32.30	285.22K
Jan 12, 2026	33.53	33.81	32.29	32.64	412.25K
Jan 09, 2026	33.53	33.95	32.84	33.00	320.92K
Jan 08, 2026	34.35	34.61	32.67	33.05	337.74K

Contact Details

Abingdon, OX14 4RY

United Kingdom

https://www.immunocore.com 441 235 438600

About Company

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in Phase I/II dose escalation trial in patients with solid tumor cancers, including non-small-cell lung (NSCLC), gastric, head and neck, ovarian, and synovial sarcoma cancers; IMC-F106C, which is in a Phase I/II dose escalation trial in patients with multiple solid tumor cancers comprising NSCLC, small-cell lung, endometrial, ovarian, cutaneous melanoma, and breast cancers. In addition, the company's programs for infectious diseases include IMC-I109V, which is in a Phase I/II clinical trial in patients with chronic hepatitis B virus; and IMC-M113V that is in pre-clinical development stage for patients with human immunosuppression virus. Further, it develops product candidates to provide precision targeted immunosuppression for the treatment of autoimmune diseases. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.

Stock Peers

ARGX

-30.56-3.59%

argenx SE$820.31 REGN

-8.645-1.12%

Regeneron Pharmaceuticals, Inc.$766.63 UTHR

-3.66-0.76%

United Therapeutics Corporation$478.93 MDGL

-15.19-3.17%

Madrigal Pharmaceuticals, Inc.$463.42 VRTX

-11.71-2.49%

Vertex Pharmaceuticals Incorporated$458.81 ALNY

-20.72-5.89%

Alnylam Pharmaceuticals, Inc.$331.24 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

2.28+0.75%

Praxis Precision Medicines, Inc.$305.62 KRYS

-1.49-0.55%

Krystal Biotech, Inc.$267.64 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current Immunocore Holdings plc (IMCR) stock price?

Immunocore Holdings plc (NASDAQ: IMCR) stock price is $30.92 in the last trading session. During the trading session, IMCR stock reached the peak price of $31.94 while $30.60 was the lowest point it dropped to. The percentage change in IMCR stock occurred in the recent session was -1.84% while the dollar amount for the price change in IMCR stock was - $0.58.

IMCR's industry and sector of operation?

The NASDAQ listed IMCR is part of Biotechnology industry that operates in the broader Healthcare sector. Immunocore Holdings plc designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of IMCR?

Mr. Sébastien Desprez
Vice President of Communications & Corporation Affairs
Clayton Robertson
Head of Investor Relations
Ms. Lily Hepworth
Gen. Counsel & Company Sec.
Dr. David Berman M.D., Ph.D.
Head of R&D
Ms. Amy Judge-Prein
Chief Compliance Officer
Dr. Bahija Jallal Ph.D.
Chief Executive Officer & Director
Ms. Tina St. Leger
Chief HR Officer & Director
Ms. Annelise Vuidepot Ph.D.
Chief Technology Officer and Head of Pipeline & Platform Research
Ms. Debra Nielsen
Chief of Staff
Mr. Brian R. Di Donato M.B.A.
Chief Financial Officer & Head of Strategy

How IMCR did perform over past 52-week?

IMCR's closing price is 33.56% higher than its 52-week low of $23.15 where as its distance from 52-week high of $40.72 is -24.06%.

How many employees does IMCR have?

Number of IMCR employees currently stands at 493.

Link for IMCR official website?

Official Website of IMCR is: https://www.immunocore.com

How do I contact IMCR?

IMCR could be contacted at phone 441 235 438600 and can also be accessed through its website. IMCR operates from 92 Park Drive, Abingdon, OX14 4RY, United Kingdom.

How many shares of IMCR are traded daily?

IMCR stock volume for the day was 1.1M shares. The average number of IMCR shares traded daily for last 3 months was 374.78K.

What is the market cap of IMCR currently?

The market value of IMCR currently stands at $1.56B with its latest stock price at $30.92 and 50.47M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	493
Beta	0.78
Sales or Revenue	$249.43M
5Y Sales Change%	4.89%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	493
Beta	0.78
Sales or Revenue	$249.43M
5Y Sales Change%	4.89%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

IMCR Company Profile and Key Details

Immunocore

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Earnings & Analyst Outlook

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook